Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Andrew D. Goldberg
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 28
- Beta
- 2.23
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -2.01
Financials
Net Income
$-74.77MEBITDA
$-74.43MFree Cash Flow
$-10.79MEPS (diluted)
$-0.80Shares Outstanding (diluted)
93.51M+685360.7%Operating Expenses
$18.39MCash & Debt
$187.30MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-54.65M | $-1.25 |
| 2024 | $0.00 | $-39.83M | $-1.24 |
| 2023 | $0.00 | $-29.82M | $-1.50 |
| 2022 | $0.00 | $-42.35M | $-3.95 |
| 2021 | $0.00 | $-33.15M | $-4.05 |
| 2020 | $0.00 | $-14.66M | $-5.39 |
| 2019 | $0.00 | $-16.39M | $-39.15 |
| 2018 | $0.00 | $-12.69M | $-72.29 |
| 2017 | $0.00 | $-10.58M | $-441.47 |
| 2016 | $5.06M | $-20.13M | $-1478.66 |
| 2015 | $18.16M | $-16.80M | $-1413.63 |
| 2014 | $27.12M | $-26.24M | $-3189.89 |
| 2013 | $29.88M | $-31.85M | $-4772.10 |
| 2012 | $20.09M | $-21.10M | $-3432.80 |
Valuation
ACHVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsglobenewswire.com·1d ago·Neutral
…ces Announced Granting of New Hire Inducement Awards SEATTLE and VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced that Achieve's board of directors approved stock option grants to purchase an aggregate of 315,000 shares of its common stock and restricted stock unit …
View source ↗
Earnings
Thu, Nov 5(in 2 months)
Consensus estimate $-0.20 per share
Typical surprise -3.7% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.80 vs $-0.16miss
- Tue, May 12$-0.19 vs $-0.30beat
- Tue, Mar 24$-0.28 vs $-0.27miss
- Thu, Nov 6$-0.28 vs $-0.24miss
- Thu, Aug 7$-0.37 vs $-0.37beat
- Tue, May 13$-0.37 vs $-0.37beat
Estimates and results for ACHV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ACHV officers and directors.
- Bought
- $57k
- Sold
- $1.3m
2 trades
7 trades
- Stewart Richard Alistairsold
- Oki Mark Ksold
- Stewart Richard Alistairsold
- Wan Jerrysold
- King Thomas Braxtonsold
- Jacobs Cindysold
- Xinos Jaimesold
- Oki Mark Kbought
91 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.